4 results  1 of 1 

1 Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological Biomarkers
Yingjia Wu, Jinbin Chen, Lei Zhao, Qiaoqiao Li, Jinhan Zhu, Hong Yang, Suping Guo, Mian Xi
Cancer Res Treat.2021;53(1):172-183.   Published online 2020 September 4     DOI: http://dx.doi.org/10.4143/crt.2020.594
      
2 Response Assessment with MRI after Chemoradiotherapy in Rectal Cancer: Current Evidences
Nieun Seo, Honsoul Kim, Min Soo Cho, Joon Seok Lim
Korean J Radiol.2019;20(7):1003-1018.   Published online 2019 June 3     DOI: http://dx.doi.org/10.3348/kjr.2018.0611
      
3 Impact of Mucin Proportion in the Pretreatment MRI on the Outcomes of Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
Eunji Kim, Kyubo Kim, Se Hyung Kim, Sae-Won Han, Tae-You Kim, Seung-Yong Jeong, Kyu Joo Park, Jaemoon Koh, Gyeong Hoon Kang, Eui Kyu Chie
Cancer Res Treat.2019;51(3):1188-1197.   Published online 2018 December 20     DOI: http://dx.doi.org/10.4143/crt.2018.434
      
4 Pathologic and Oncologic Outcomes in Locally Advanced Gastric Cancer with Neoadjuvant Chemotherapy or Chemoradiotherapy
Ji Yeong An, Hyoung-Il Kim, Jae-Ho Cheong, Woo Jin Hyung, Choong Bae Kim, Sung Hoon Noh
Yonsei Med J.2013;54(4):888-894.   Published online 2013 May 14     DOI: http://dx.doi.org/10.3349/ymj.2013.54.4.888
      

 1 of 1